Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEHP.L Share News (EHP)

  • There is currently no data for EHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Nautical Petroleum, ThirdForce, Allied Gold...

Mon, 09th Nov 2009 11:43

Oil group Nautical Petroleum reported 'significant progress' in its asset portfolio in the year to June 30 and said it expects its assets to rise in value once they move into the execution stage.Pre-tax losses for the year totalled £6.63m, compared with £4.52m the previous year.Shares in e-learning software group ThirdForce jumped after its chief executive and chairman made a formal offer for the company.The directors, who have set up an investment vehicle called LearnVantage, offered shareholders one LearnVantage share for every ThirdForce share, three LearnVantage shares plus €0.12 for every four ThirdForce shares or €0.105 for every ThirdForce share.Allied Gold's takeover offer for Australian Solomons Gold has gone unconditional, giving the miner 49% of the business.Those ASG shareholders who accepted the offer will get 0.85 Allied shares for every ASG share held. Allied expects further acceptances."This is a milestone in Allied Gold's emergence as a substantial South East Asian gold producer with a clear production development profile that will see the company producing in excess of 250,000 oz of gold," said Allied's executive chairman, Mark Caruso. Greystar Resources, which owns the Angostura gold-silver deposit in northeastern Colombia, is to start two exploration drill programs to investigate near surface oxide gold mineralization recently discovered at the Mongora prospect.The first drill holes will target the Los Laches area at Angostura where previously drilled core holes LL08-24 and QP08-03 returned "excellent" results.Uruguay Mineral Exploration and Canada's Fortune Valley Resources have completed their merger, creating a more significant Latin American focused gold producer.Mixed phase catalyst technology developer Catalytic Solutions saw its pre-tax loss narrow to $7.94m in the first half of 2009 from $9.92m a year earlier on revenue that grew from $26.83m to $27.65m.The company's shares remain suspended while it tackles its liquidity crisis. The company is in talks over short-term financing to give it breathing space to sort out longer term facilities.Electronic payments company Earthport said its services are gaining popularity among Exchange Houses in the United Arab Emirates (UAE). Earthport is the exclusive provider of 'to bank' remittance services in 119 Exchange House branches in the UAE, and expects to see further adoption of the service before the end of the year in the UAE, Kuwait, Oman and Jordan.Shares in ReGen Therapeutics were wanted after the pharma company announced more good news relating to its Zolpidem project, Results of tests conducted in South Africa indicate that zolpidem significantly boosts the cognitive and motor performance of brain damage victims.Drug testing group Epistem is to present the clinical results of two recently completed studies on hair follicle analysis at the AACR-NCI-EORTC conference in Boston next week.The first study demonstrates androgen receptor pathway activity in hair from elderly volunteers, while in the second, a phase I study, novel pharmacodynamic markers for Enzon Pharmaceuticals Inc's survivin messenger ribonucleic acid (mRNA) antagonist were identified from hair follicle analysis. Dr. Ged Brady will present data which demonstrates plucked human scalp hairs as a preferred method for assessing androgen receptor directed therapies, the company said.Tristel, which provides infection and contamination control products, has raised £2m through a placing.It will use the funds to accelerate expansion of its overseas businesses, the company said.
More News
28 Oct 2014 08:27

Epistem Files For Import, Sales Licence For Genedrive In India

Read more
22 Jul 2014 09:23

Epistem Expects Full Year Loss, Signs Funding Agreement For Genedrive

Read more
7 Apr 2014 16:00

DIRECTOR DEALINGS: Epistem Holdings Managing Director Transfers Shares

LONDON (Alliance News) - Epistem Holdings PLC Monday said Managing Director Catherine Booth transferred 4,877 shares to her self invested personal pension fund at a price of 328 pence. Booth's interest remains unchanged at 985,642 shares following this transaction, representing a 10.11% sta

Read more
25 Mar 2014 13:12

Epistem Loss Widens As It Ups Investment, Revenue Declines

LONDON (Alliance News) - Epistem Holdings PLC Tuesday posted a widened pretax loss as it saw revenue decline in the half-year ended December 31, 2013, and it upped its investment in the development of its Genedrive product. Genedrive is a molecular diagnostic technology. Epistem poste

Read more
25 Mar 2014 06:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 25 
888 Holdi

Read more
24 Mar 2014 15:39

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 25 
888 Holdi

Read more
27 Jan 2014 10:15

EpiStem Appoints COO And Technical Director For Diagnostics Division

LONDON (Alliance News) - EpiStem Holdings PLC said Monday that it had appointed for its Diagnostics division Allan Brown as chief operating office and Peter Foster as technical director. Brown will take on the role February 1. He previously held positions at Tepnel Life Sciences PLC and QIA

Read more
3 Dec 2013 15:59

Hangar 8 CEO makes first sale to meet demand for stock

Hangar 8, a privately-owned passenger jet aircraft owner, announced that Dustin Dryden, its Chief Executive Office, made his first ever sale of company stock with the disposal of 750,000 shares to meet institutional demand. Dryden sold the shares at 205p each for a total of £1.54m and reduced his

Read more
19 Nov 2013 15:56

Neptune Calculus Income & Growth VCT Hit By Epistem Share Decline

Read more
22 Oct 2013 11:41

UPDATE: Epistem Widens Pretax Losses Following Delays Of Key Product, Looking To Launch In 2014

Read more
22 Oct 2013 08:05

Epistem Widens Pretax Losses Following Delays Of Key Product

Read more
7 Oct 2013 10:12

DIRECTOR DEALINGS: Epistem Chief Executive, Directors Acquire Shares

Read more
9 Sep 2013 11:37

UK Winners & Losers: BG Down 5%, CSR Up 5%; Mediazest Drops 21%

Read more
9 Sep 2013 11:34

Epistem Holdings Says Expansion Talks With US Becton Dickinson Failed

Read more
9 Sep 2013 08:00

EpiStem loses distribution contract for TB test

AIM-listed biotech firm EpiStem has maintained its full-year guidance for the period just gone but admitted that talks over a key supply and distribution agreement for its TB test have fallen through. The company was in discussions with medical technology company Becton Dickinson (BD) to expand the

Read more

Quickpicks are a member only feature

Login to your account